UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022004
Receipt number R000025357
Scientific Title Real-world EValuation of the antithrombotic thErapy And clinicaL outcomes for the patients with Atrial Fibrillation undergoing Percutaneous Coronary Intervention
Date of disclosure of the study information 2016/05/01
Last modified on 2016/04/20 20:07:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Real-world EValuation of the antithrombotic thErapy And clinicaL outcomes for the patients with Atrial Fibrillation undergoing Percutaneous Coronary Intervention

Acronym

REVEAL AF-PCI Registry

Scientific Title

Real-world EValuation of the antithrombotic thErapy And clinicaL outcomes for the patients with Atrial Fibrillation undergoing Percutaneous Coronary Intervention

Scientific Title:Acronym

REVEAL AF-PCI Registry

Region

Japan


Condition

Condition

Atrial Fibrillation
Coronary Artery Disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the status of the antiplatelet regimen and clinical outcomes among atrial fibrillation patients treated with percutaneous coronary intervetion.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Composite of death, myocardial infarction, stent thrombosis, stroke, and systemic embolism at 1-year from the index percutaneous coronary intervention.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients treated by percutaneous coronary intervention (PCI).
2. Patients diagnosed as atrial fibrillation at the time of index PCI.

Key exclusion criteria

Patients who denied participation.

Target sample size

5000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takeshi Kimura

Organization

Kyoto University Graduate School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code


Address

54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507 Japan

TEL

075-751-4255

Email

totoyota@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Toshiaki Toyota

Organization

Kyoto University Graduate School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code


Address

54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507 Japan

TEL

075-751-4255

Homepage URL


Email

totoyota@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Department of Clinical Epidemiology, Hyogo College of Medicine

Institute

Department

Personal name



Funding Source

Organization

Kyoto University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

R0185

Org. issuing International ID_1

Kyoto University Graduate School of Medicine

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Date of protocol fixation

2015 Year 09 Month 18 Day

Date of IRB


Anticipated trial start date

2015 Year 09 Month 24 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Analysis of antiplatelet regimen, patient baseline characteristics, and the details of the PCI procedures will be performed.


Management information

Registered date

2016 Year 04 Month 20 Day

Last modified on

2016 Year 04 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025357


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name